Publications of A. Ullrich
All genres
Journal Article (154)
41.
Journal Article
4 (4), pp. 323 - 334 (2010)
Somatic mutation in the ACK1 ubiquitin association domain enhances oncogenic signaling through EGFR regulation in renal cancer derived cells. Molecular Oncology 42.
Journal Article
51 (4), pp. 1383 - 1390 (2010)
Mitogen-Inducible Gene-6 is a Negative Regulator of Epidermal Growth Factor Receptor Signaling in Hepatocytes and Human Hepatocellular Carcinoma. Hepatology 43.
Journal Article
29 (10), pp. 1543 - 1552 (2010)
The FGFR4 Y367C mutant is a dominant oncogene in MDA-MB453 breast cancer cells. Oncogene 44.
Journal Article
70 (2), pp. 802 - 812 (2010)
A Single Nucleotide Change in the Mouse Genome Accelerates Breast Cancer Progression. Cancer Research 45.
Journal Article
5 (1), p. I - I (2010)
PREFACE. Current Signal Transduction Therapy 46.
Journal Article
8, 131, pp. [1] - [12] (2009)
Regulation of Akt(ser473) phosphorylation by Choline kinase in breast carcinoma cells. Molecular Cancer 47.
Journal Article
199 (3-4 Sp. Iss.), pp. 279 - 297 (2009)
Protein tyrosine phosphatases expression during development of mouse superior colliculus. Experimental Brain Research 48.
Journal Article
28 (37), pp. 3320 - 3331 (2009)
Overexpression of Csk-binding protein contributes to renal cell carcinogenesis. Oncogene 49.
Journal Article
35 (3), pp. 291 - 304 (2009)
Negative Regulation of the EGFR-MAPK Cascade by Actin-MAL-Mediated Mig6/Errfi-1 Induction. Molecular Cell 50.
Journal Article
124 (6), pp. 1293 - 1300 (2009)
Effects of sunitinib on tumor hemodynamics and delivery of chemotherapy. International Journal of Cancer 51.
Journal Article
15 (6), pp. 2058 - 2066 (2009)
Resistance to Chemotherapy Is Associated with Fibroblast Growth Factor Receptor 4 Up-Regulation. Clinical Cancer Research 52.
Journal Article
50 (1), pp. 118 - 127 (2009)
Fibroblast growth factor receptor 4 regulates proliferation, anti-apoptosis and alpha-fetoprotein secretion during hepatocellular carcinoma progression and represents a potential target for therapeutic intervention. Journal of Hepatology 53.
Journal Article
124 [2009] (3), pp. 531 - 539 (2008)
UV-induced EGFR signal transactivation is dependent on proligand shedding by activated metalloproteases in skin cancer cell lines. International Journal of Cancer 54.
Journal Article
28 (5C), p. 332 (2008)
SIGNAL TRANSDUCTION THERAPY OF TUMORS WITH MULTIPLE TARGET KINASE INHIBITORS. Anticancer Research 55.
Journal Article
7 (9), pp. 1763 - 1777 (2008)
Investigation of protein-tyrosine phosphatase 1B function by quantitative proteomics. Molecular & Cellular Proteomics 56.
Journal Article
14 (16), pp. 5188 - 5197 (2008)
HER3 is a determinant for poor prognosis in melanoma. Clinical Cancer Research 57.
Journal Article
20 (7), pp. 1385 - 1391 (2008)
SHPS-1/SIRP1 alpha contributes to interleukin-6 signalling. Cellular Signalling 58.
Journal Article
8 (6), pp. 473 - 480 (2008)
Paul Ehrlich's magic bullet concept: 100 years of progress. Nature Reviews Cancer 59.
Journal Article
275 (Suppl. Suppl. 1), p. 1 - 1 (2008)
Targeted cancer therapies: herceptin and SUTENT. FEBS Journal 60.
Journal Article
13 (5), pp. 441 - 453 (2008)
Direct genetic analysis of single disseminated cancer cells for prediction of outcome and therapy selection in esophageal cancer. Cancer Cell